Serum glucose level at hospital admission correlates with left ventricular systolic dysfunction in nondiabetic, acute coronary patients: The hellenic heart failure study

Heart and Vessels

Volumn 25, Issue 3, 2010, Pages 209-216

  Chrysohoou, Christina ^a   Pitsavos, Christos ^a   Aggelopoulos, Panagiotis ^a   Skoumas, John ^a   Tsiamis, Eleftherios ^a   Panagiotakos, Demosthenes B ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute coronary syndrome; Glucose; Systolic dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; GLUCOSE; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE CLEARANCE; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SYSTOLIC DYSFUNCTION;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CREATININE; FEMALE; GREECE; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PATIENT ADMISSION; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; SYSTOLE; TROPONIN; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 77956139520     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1192-8     Document Type: Article

References (40)

1. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA Jr, Granger CB (2006) Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333:1091-1097
2. Mollema SA, Nucifora G, Bax JJ (2009) Prognostic value of echocardiography after acute myocardial infarction. Heart 95:1732-1745
3. The DECODE Study Group and on behalf of the European Diabetes Epidemiology Group (2003) Is the current definition of diabetes relevant to mortality risk from all causes and cardiovascular and non cardiovascular disease? Diabetes Care 26:688-696
4. Lehto S, Pyorala K, Miettinen H, Ronnemaa T, Palomaki P, Tuomilehto J, Laakso M (1994) Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus. J Intern Med 236:291-297
5. Müdespacher D, Radovanovic D, Camenzind E, Essig M, Bertel O, Erne P, Eberli FR, Gutzwiller F; Amis Plus Investigators (2007) Admission glycaemia and outcome in patients with acute coronary syndrome. Diabet Vasc Dis Res 4:346-352
6. Zeller M, Vergès B, L'Huillier I, Brun JM, Cottin Y (2006) Glycemia in acute coronary syndromes. Diabetes Metab 32:2S42-S47
7. Frankenstein L, Clark AL, Goode K, Ingle L, Remppis A, Schellberg D, Grabs F, Nelles M, Cleland JG, Katus HA, Zugck C (2009) The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart 95:825-829
8. Undas A, Wiek I, Stêpien E, Zmudka K, Tracz W (2008) Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 31:1590-1595
9. Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH, Avezum A; GRACE Investigators (2009) Association of elevated fasting glucose with increased short-term and 6-month mortality in STsegment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 169:402-409
10. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Lévy S, Linde C, Lopez-Sendon JL, Nieminen MS, Piérard L, Remme WJ (2005) Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115-1140
11. Thygesen K, Alpert JS, White HD on behalf of the joint ESC/ ACCF/AHA/WHF Task force for the redefinition of myocardial infarction (2007) Universal definition of myocardial infarction Eur Heart J 28:2525-2538 (Pubitemid 47616190)
12. Braunwald E (1997) Heart disease. 5th edn. Saunders, London
13. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
14. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381-1395
15. McGuire DK, Emanuelsson H, Granger CB, Magnus Ohman E, Moliterno DJ, White HD, Ardissino D, Box JW, Califf RM, Topol EJ (2000) Infl uence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb investigators. Eur Heart J 21:1750-1758
16. Pinto DS, Skolnick AH, Kirtane AJ (2005) U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 46:178-180
17. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M (2005) Association between hyper-and hypoglycaemia and 2 year allcause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26:1255-1261
18. Ikeda N, Nakajima R, Tsunoda T, Nakamura M, Sugi K (2007) Insulin resistance and acute coronary syndrome in the young Japanese population have a strong association. Heart Vessels 22: 165-169
19. Bhadriraju S, Ray KK, DeFranco AC, Barber K, Bhadriraju P, Murphy SA, Morrow DA, McCabe CH, Gibson CM, Cannon CP, Braunwald E (2006) Association between blood glucose and longterm mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial. Am J Cardiol 97:1573-1577
20. Capes SE, Hunt D, Malmberg K, Gerstein HC (2000). Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778
21. Kasai T, Miyauchi K, Kajimoto K (2008) Infl uence of diabetes on 10year outcomes after percutaneous coronary intervention. Heart Vessels 23:149-154
22. Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778
23. Nesto RW, Lago RM (2008) Glucose a biomarker in acute myocardial infarction ready for prime time? Circulation 117: 990-992
24. Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, McCabe CH, Gibson CM, Braunwald E (2007) Synergistic relationship between hyperglycaemia and infl ammation with respect to clinical outcomes in non-ST elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 28:806-813
25. Verma S, Wang CH, Weisel RD, Badiwala MV, Li SH, Fedak PW, Li RK, Mickle DA (2003) Hyperglycaemia potentates the proatherogenic effects of C reactive protein: reversal with rosiglitazone. J Moll Cell Cardiol 35:417-419
26. Morohoshi M, Fujisawa K, Uchimura I, Numano F (1995) The effect of glucose and advanced glucosylation end products on IL6 production by human monocytes. Ann N Y Acad Sci 748: 562-570
27. Yamagishi S, Fujimoro H, Yonekura H, Yamamoto Y, Yamamoto H (1998) Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia 41:1435-1441
28. Zhang J, Ren S, Sun D, Shen GX (1998) Infl uence of glycation onLDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Arterioscler Thromb Vasc Biol 18:1140-1148
29. Stranders I, Diamant M, Van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164:982-988
30. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses fl ow-mediated endothelium dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146-154
31. Nicolaou VN, Papadakis JE, Chrysohoou C, Panagiotakos DB, Krinos X, Skoufas PD, Stefanadis C (2008) The prognostic signifi-cance of serum glucose levels after the onset of ventricular arrhythmia on in-hospital mortality of patients with acute coronary syndrome. Rev Diabet Stud 5:47-51
32. Maimberg K, Norhammar A, Wedel H, Ryden L (1999) Glucometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and myocardial infarction: long term results from the Diabetes and Insulin-Glucose infusion in Acute Myocardial Infarction (DIGAMI study). Circulation 99:2626-2632
33. Barron H, Cannon C, Murphy S, Braunwald E, Gibson M (2000) Association between white blood cell count, epicardial blood fl ow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a Thrombolysis In Myocardial Infarction 10 substudy. Circulation 102:2329-2334
34. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Quiles J, Zouridakis E, Kaski JC (2004) Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 175:151-157
35. Jolly S, Kane W, Hook B, Abrams G, Kunkel S, Lucchesi B (1986) Reduction of myocardial infarct size by neutrophil depletion: Effect of duration of occlusion. Am Heart J 112:682-690
36. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV (2008) Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function. Hellenic J Cardiol 49:26-32
37. Zebrack J, Muhlestein J, Horne B, Anderson J (2002) C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39:632-637
38. Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endothelium dependent coronary vasodilation in nondiabetic patients. Heart Vessels 23:9-15
39. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M (2005) Association between hyper-and hypoglycaemia and 2-year allcause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26:1255-1261
40. Pinto D, Skolnick A, Kirtane A, Murphy S, Barron H, Giugliano R, Cannon C, Braunwald E, Gibson C (2005) U-shaped relationship of blood glucose with adverse outcomes among patients with STsegment elevation myocardial infarction. J Am Coll Cardiol 46:178-180